New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics
Welcome to the January 2015 issue of PharmSource PERISCOPE
This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.
Enjoy the January issue, and Happy New Year!
PharmSource Lead Sheet Global Activity Report:
|Lead Type||December 2014||2014 YTD|
|Total Drug Leads||366||4257|
|Total Device &
*Total leads include acquisitions/alliances, company acquisition/alliances and events.
Protalix plans to begin clinical trials in 2015 with PRX-110, a plant cell-expressed recombinant human deoxyribonuclease 1 enzyme administered by inhalation, for the treatment of cystic fibrosis. Results are expected in early 2016. Learn more.
PharmSource PERISCOPE: How it Benefits You Directly
by Katie Ludwick, Marketing Manager
PharmSource PERISCOPE is carefully crafted each month to provide you with useful information that will support your BD efforts.
Each issue covers a variety of topics designed to help you recognize new business opportunities and overcome sales obstacles.
The PharmSource Lead Sheet Global Activity Report chart in an important snapshot that shows the number and nature of leads that were covered in the PharmSource Lead Sheet during the previous month and year-to-date. Following this from month-to-month can give good insight into… read on
New Year, New Tactics for (Sales) Productivity
Even if you’re not a fan of New Year resolutions, you may want to consider some of the productivity tips suggested in a recent issue of Inc. magazine. 23 Best Productivity Hacks: This year’s best tips for boosting productivity, by Larry Kim, offers several very simple techniques that can easily – even painlessly – be implemented. These can contribute to general productivity, including sales productivity… read on
PharmSource Trend Reports
- Learn about trends that guide the way for optimal decision-making.
- Get data-driven market intelligence and insight from PharmSource’s experts.
Demand and Supply for Contract Manufacturing of Conventional Injectable Drugs Through 2019
Expert quantitative analysis on the latest trends and plans for outsourcing commercially approved injectable products.
List Price: US $7,500
Not So NICE:
How Market Access Schemes Impact the CMO Sector
The impact to CMOs of Europe’s government-funded economic health hurdles and de-facto US drug rationing.
List Price: US $997
Opportunity Knocks: In-Licensed Drug Products Can Signal Outsourcing Opportunity
This data-driven analysis shows in-licensing of NMEs is a relevant indicator of new outsourced manufacturing opportunity.
List Price: US $750
Contact us today for a discount when you purchase any two or more of our Trend Reports: email@example.com | +1-703-383-4903.
PharmSource Lead Sheet
The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.
Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.
See for yourself how this resource can be a vital tool for building your brand and growing your market share.
To request a test-drive today, contact Nathaniel Celentano at firstname.lastname@example.org / 1-703-383-4903, ext. 112 (ET USA).